Hitoshi Okada

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Cell death & disease

Molecular cancer research : MCR

Scientific reports

Genes to cells : devoted to molecular & cellular mechanisms

University of Toronto

Tohoku University Graduate School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Toronto May 01 2005 - Mar 31 2014

Canada

Professor (Assisatnt & Associate) :: Department of Medical Biophysics

Princess Margaret Cancer Centre May 01 2005 - Mar 31 2014

Canada

Sientist

Ontario Cancer Institute Mar 01 1999 - Apr 30 2005

Canada

Postdoctoral Fellow

Japanese Foundation For Cancer Research May 01 1995 - Feb 28 1998

Japan

Research Scientist :: Cell Biology

Education History

Tohoku University Graduate School of Medicine Apr 01 1991 - Mar 31 1995

Japan

PHD

Publications

Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (5) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (5) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Masahiko Honda, Ryota Inoue, Kuniyuki Nishiyama, Takeshi Ueda, Akiyoshi Komuro, Hisayuki Amano, Ryoichi Sugisawa, Suman Dash, Jun Shirakawa, Hitoshi Okada
Vgll2 as an integrative regulator of mitochondrial function and contractility specific to skeletal muscle. Journal of cellular physiology (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Hisayuki Amano, Masahiko Honda, Masahito Kawazu, Hitoshi Okada
MYC/glutamine dependency is a therapeutic vulnerability in pancreatic cancer with deoxycytidine kinase inactivation-induced gemcitabine resistance. Molecular cancer research : MCR (2023)
Naohiro Oka, Akiyoshi Komuro, Hisayuki Amano, Suman Dash, Masahiko Honda, Kazushige Ota, Shunji Nishimura, Takeshi Ueda, Masao Akagi, Hitoshi Okada
Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin. Pharmacology research & perspectives 8 (4) (2021)
Kazushige Ota, Akiyoshi Komuro, Hisayuki Amano, Akinori Kanai, Kai Ge, Takeshi Ueda, Hitoshi Okada
High Fat Diet Triggers a Reduction in Body Fat Mass in Female Mice Deficient for Utx demethylase. Scientific reports 9 (1) (2019)
Changkeun Kang, Kayoko Saso, Kazushige Ota, Masahito Kawazu, Takeshi Ueda, Hitoshi Okada
JMJD2B/KDM4B inactivation in adipose tissues accelerates obesity and systemic metabolic abnormalities. Genes to cells : devoted to molecular & cellular mechanisms 23 (9) (2018)

Hitoshi Okada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hitoshi Okada